(Q33497225)

27 July 2017

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium (English)

1 reference

transitional cell carcinoma

27 July 2017

1 reference

Small EJ

1

1 reference

27 July 2017

Fippin LJ

series ordinal

2

1 reference

27 July 2017

Ernest ML

series ordinal

3

1 reference

27 July 2017

Carroll PR

series ordinal

4

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

27 July 2017

1 reference

27 July 2017

78

1 reference

27 July 2017

1775-1780

1 reference

27 July 2017

8

1 reference

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

27 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

MVAC for bladder cancer: time to move forward again

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

New combination chemotherapy programme for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Carboplatin, Methotrexate and Vinblastin (Carbo-MV) for Advanced Urothelial Cancer A Phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Carboplatin-based chemotherapy for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1775%3A%3AAID-CNCR18%3E3.0.CO%3B2-V

10.1002/(SICI)1097-0142(19961015)78:8<1775::AID-CNCR18>3.0.CO;2-V

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference